Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance - PubMed (original) (raw)

Randomized Controlled Trial

. 2010 Jan 15;105(2):198-204.

doi: 10.1016/j.amjcard.2009.08.672. Epub 2009 Nov 26.

Affiliations

• PMID: 20102918
• DOI: 10.1016/j.amjcard.2009.08.672

Randomized Controlled Trial

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance

Steven C Halbert et al. Am J Cardiol. 2010.

Abstract

Currently, no consensus has been reached regarding the management of hyperlipidemia in patients who develop statin-associated myalgia (SAM). Many statin-intolerant patients use alternative lipid-lowering therapies, including red yeast rice. The present trial evaluated the tolerability of red yeast rice versus pravastatin in patients unable to tolerate other statins because of myalgia. The study was conducted in a community-based setting in Philadelphia, Pennsylvania. A total of 43 adults with dyslipidemia and a history of statin discontinuation because of myalgia were randomly assigned to red yeast rice 2,400 mg twice daily or pravastatin 20 mg twice daily for 12 weeks. All subjects were concomitantly enrolled in a 12-week therapeutic lifestyle change program. The primary outcomes included the incidence of treatment discontinuation because of myalgia and a daily pain severity score. The secondary outcomes were muscle strength and plasma lipids. The incidence of withdrawal from medication owing to myalgia was 5% (1 of 21) in the red yeast rice group and 9% (2 of 22) in the pravastatin group (p = 0.99). The mean pain severity did not differ significantly between the 2 groups. No difference was found in muscle strength between the 2 groups at week 4 (p = 0.61), week 8 (p = 0.81), or week 12 (p = 0.82). The low-density lipoprotein cholesterol level decreased 30% in the red yeast rice group and 27% in the pravastatin group. In conclusion, red yeast rice was tolerated as well as pravastatin and achieved a comparable reduction of low-density lipoprotein cholesterol in a population previously intolerant to statins.

Copyright 2010 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Comment in

• Red yeast rice and statin-intolerant patients.
  Cicero AF, Derosa G, Borghi C. Cicero AF, et al. Am J Cardiol. 2010 May 15;105(10):1504. doi: 10.1016/j.amjcard.2010.01.337. Am J Cardiol. 2010. PMID: 20451704 No abstract available.

Similar articles

• Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
  Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Becker DJ, et al. Ann Intern Med. 2009 Jun 16;150(12):830-9, W147-9. doi: 10.7326/0003-4819-150-12-200906160-00006. Ann Intern Med. 2009. PMID: 19528562 Clinical Trial.
• Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.
  Becker DJ, French B, Morris PB, Silvent E, Gordon RY. Becker DJ, et al. Am Heart J. 2013 Jul;166(1):187-96. doi: 10.1016/j.ahj.2013.03.019. Epub 2013 Apr 30. Am Heart J. 2013. PMID: 23816039 Clinical Trial.
• Lipid-lowering efficacy of red yeast rice in a population intolerant to statins.
  Venero CV, Venero JV, Wortham DC, Thompson PD. Venero CV, et al. Am J Cardiol. 2010 Mar 1;105(5):664-6. doi: 10.1016/j.amjcard.2009.10.045. Am J Cardiol. 2010. PMID: 20185013
• The role of red yeast rice for the physician.
  Gordon RY, Becker DJ. Gordon RY, et al. Curr Atheroscler Rep. 2011 Feb;13(1):73-80. doi: 10.1007/s11883-010-0145-0. Curr Atheroscler Rep. 2011. PMID: 21061097 Review.
• Statin intolerance: now a solved problem.
  Sikka P, Kapoor S, Bindra VK, Sharma M, Vishwakarma P, Saxena KK. Sikka P, et al. J Postgrad Med. 2011 Oct-Dec;57(4):321-8. doi: 10.4103/0022-3859.90085. J Postgrad Med. 2011. PMID: 22120862 Review.

Cited by

• Red yeast rice for dysipidemia.
  Shamim S, Al Badarin FJ, DiNicolantonio JJ, Lavie CJ, O'Keefe JH. Shamim S, et al. Mo Med. 2013 Jul-Aug;110(4):349-54. Mo Med. 2013. PMID: 24003656 Free PMC article. Review.
• Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High-Quality Randomized Controlled Trials.
  Li P, Wang Q, Chen K, Zou S, Shu S, Lu C, Wang S, Jiang Y, Fan C, Luo Y. Li P, et al. Front Pharmacol. 2022 Jan 17;12:819482. doi: 10.3389/fphar.2021.819482. eCollection 2021. Front Pharmacol. 2022. PMID: 35111069 Free PMC article. Review.
• Mediterranean Diet and Red Yeast Rice Supplementation for the Management of Hyperlipidemia in Statin-Intolerant Patients with or without Type 2 Diabetes.
  Sartore G, Burlina S, Ragazzi E, Ferraresso S, Valentini R, Lapolla A. Sartore G, et al. Evid Based Complement Alternat Med. 2013;2013:743473. doi: 10.1155/2013/743473. Epub 2013 Dec 23. Evid Based Complement Alternat Med. 2013. PMID: 24454511 Free PMC article.
• Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia.
  Di Pierro F, Putignano P, Ferrara T, Raiola C, Rapacioli G, Villanova N. Di Pierro F, et al. Clin Pharmacol. 2016 Dec 21;9:1-7. doi: 10.2147/CPAA.S120032. eCollection 2017. Clin Pharmacol. 2016. PMID: 28058034 Free PMC article.
• Red yeast rice for the treatment of dyslipidemia.
  Burke FM. Burke FM. Curr Atheroscler Rep. 2015 Apr;17(4):495. doi: 10.1007/s11883-015-0495-8. Curr Atheroscler Rep. 2015. PMID: 25728312 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Medical

  • MedlinePlus Health Information